JPS5418331B2 - - Google Patents

Info

Publication number
JPS5418331B2
JPS5418331B2 JP3886373A JP3886373A JPS5418331B2 JP S5418331 B2 JPS5418331 B2 JP S5418331B2 JP 3886373 A JP3886373 A JP 3886373A JP 3886373 A JP3886373 A JP 3886373A JP S5418331 B2 JPS5418331 B2 JP S5418331B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP3886373A
Other languages
Japanese (ja)
Other versions
JPS497415A (cg-RX-API-DMAC7.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS497415A publication Critical patent/JPS497415A/ja
Publication of JPS5418331B2 publication Critical patent/JPS5418331B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D1/00—Evaporating
    • B01D1/16—Evaporating by spraying
    • B01D1/18—Evaporating by spraying to obtain dry solids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP3886373A 1972-04-10 1973-04-06 Expired JPS5418331B2 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24278972A 1972-04-10 1972-04-10

Publications (2)

Publication Number Publication Date
JPS497415A JPS497415A (cg-RX-API-DMAC7.html) 1974-01-23
JPS5418331B2 true JPS5418331B2 (cg-RX-API-DMAC7.html) 1979-07-06

Family

ID=22916188

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3886373A Expired JPS5418331B2 (cg-RX-API-DMAC7.html) 1972-04-10 1973-04-06

Country Status (8)

Country Link
JP (1) JPS5418331B2 (cg-RX-API-DMAC7.html)
AT (1) AT353232B (cg-RX-API-DMAC7.html)
BE (1) BE797921A (cg-RX-API-DMAC7.html)
CH (1) CH586568A5 (cg-RX-API-DMAC7.html)
DE (1) DE2317434A1 (cg-RX-API-DMAC7.html)
FR (1) FR2179899B1 (cg-RX-API-DMAC7.html)
GB (1) GB1422974A (cg-RX-API-DMAC7.html)
NL (1) NL7304921A (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58154547A (ja) * 1982-03-09 1983-09-14 Nippon Shinyaku Co Ltd アズレン誘導体の安定化法
JP2546838B2 (ja) * 1986-03-24 1996-10-23 エフ・ホフマン―ラ ロシユ アーゲー ビタミン製剤の製造方法
JP3555640B2 (ja) * 1996-05-10 2004-08-18 ライオン株式会社 天然カロチノイドを包含した多芯型構造のマイクロカプセル並びに錠剤、食品用及び医薬品用配合剤
JP4815053B2 (ja) * 1998-08-13 2011-11-16 シーマ・ラブス、インコーポレイテッド 経口投与の固形投与形態物としてのマイクロエマルション
JP2000086537A (ja) * 1998-09-11 2000-03-28 Fuji Chem Ind Co Ltd 無機化合物糖類組成物、賦形剤、速崩壊性圧縮成型物及びその製造方法
WO2002083102A1 (en) * 2001-02-23 2002-10-24 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
US8080172B2 (en) 2006-01-18 2011-12-20 J.I. Enterprises, Inc. Method and composition for controlled heat release and disposable chemical heater utilizing same
PT3150586T (pt) 2007-02-23 2020-03-31 Gilead Sciences Inc Moduladores de propriedades farmacocinéticas de agentes terapêuticos
US20080254119A1 (en) 2007-04-16 2008-10-16 Wyeth Imbedded liquid lubricants for tableting
EA201591353A1 (ru) 2008-05-02 2016-01-29 Джилид Сайэнс, Инк. Применение частиц твердого носителя для улучшения технологических характеристик фармацевтического агента
ES2684327T5 (es) * 2010-12-27 2022-03-01 Dsm Ip Assets Bv Formulaciones de vitamina E en polvo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1266902A (fr) * 1960-09-06 1961-07-17 Procédé de production de préparations stables de vitamines
FR1546920A (fr) * 1966-12-02 1968-11-22 Niro Atomizer As Roue d'atomisation simultanée de deux composants
US3608083A (en) * 1968-06-05 1971-09-21 Hoffmann La Roche Vitamin e powder

Also Published As

Publication number Publication date
GB1422974A (en) 1976-01-28
CH586568A5 (cg-RX-API-DMAC7.html) 1977-04-15
AT353232B (de) 1979-11-12
JPS497415A (cg-RX-API-DMAC7.html) 1974-01-23
NL7304921A (cg-RX-API-DMAC7.html) 1973-10-12
FR2179899A1 (cg-RX-API-DMAC7.html) 1973-11-23
ATA310873A (de) 1979-04-15
DE2317434A1 (de) 1973-12-06
BE797921A (fr) 1973-10-09
FR2179899B1 (cg-RX-API-DMAC7.html) 1976-09-10

Similar Documents

Publication Publication Date Title
FR2179899A1 (cg-RX-API-DMAC7.html)
JPS5321551B2 (cg-RX-API-DMAC7.html)
JPS517444B2 (cg-RX-API-DMAC7.html)
JPS4911275U (cg-RX-API-DMAC7.html)
JPS4979854A (cg-RX-API-DMAC7.html)
FR2171373A1 (cg-RX-API-DMAC7.html)
CH571105B5 (cg-RX-API-DMAC7.html)
CH563039A5 (cg-RX-API-DMAC7.html)
CH563177A5 (cg-RX-API-DMAC7.html)
CH561861A5 (cg-RX-API-DMAC7.html)
CH559974A5 (cg-RX-API-DMAC7.html)
CH570407A5 (cg-RX-API-DMAC7.html)
CH567161A5 (cg-RX-API-DMAC7.html)
CH566143A5 (cg-RX-API-DMAC7.html)
CH577110A5 (cg-RX-API-DMAC7.html)
CH1291872A4 (cg-RX-API-DMAC7.html)
CH566677A5 (cg-RX-API-DMAC7.html)
CH566148A5 (cg-RX-API-DMAC7.html)
BG18653A1 (cg-RX-API-DMAC7.html)
CH579673B5 (cg-RX-API-DMAC7.html)
BG17922A1 (cg-RX-API-DMAC7.html)
CH567606B5 (cg-RX-API-DMAC7.html)
CH562354A5 (cg-RX-API-DMAC7.html)
BG21763A1 (cg-RX-API-DMAC7.html)
CH572791A5 (cg-RX-API-DMAC7.html)